NATHAN MORGAN: Open Payments
NPI 1215364674 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,791 in 224 payments from 23 companies in 2025. Trend: 2023 $15,403 · 2024 $12,289 · 2025 $8,791
Food & beverage: $3,858Consulting: $2,738Travel & lodging: $1,821Education: $374
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 30 | $4,224 |
| LEO Pharma Inc. | 10 | $790 |
| Janssen Biotech, Inc. | 33 | $679 |
| UCB, Inc. | 19 | $547 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $378 |
| ABBVIE INC. | 16 | $360 |
| GENZYME CORPORATION | 6 | $305 |
| Regeneron Healthcare Solutions, Inc. | 11 | $236 |
| Organon LLC | 10 | $210 |
| PFIZER INC. | 21 | $204 |
Products named: Zoryve, ADBRY, TREMFYA, Bimzelx, DUPIXENT, VTAMA, COSENTYX, ILUMYA.
Industry payments across NV — which companies pay providers there.
